Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 EX-2.1
- 2.2 EX-2.2
- 2.3 EX-2.3
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1_1
- 4.1 EX-4.1_2
- 4.1 EX-4.1_3
- 4.1 EX-4.1_4
- 4.2 EX-4.2
- 4.2 EX-4.2_1
- 4.3 EX-4.3
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.6 EX-10.6
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 21.1 EX-21.1
- 22.1 EX-22.1
- 23.1 EX-23.1
- EX-FILING FEES Ex-filing Fees
Associated filings
- 11 Sep 24 8-K 1 Endo Investor Presentation September 2024
- 29 Aug 24 424B3 Prospectus supplement
- 2024 Q2 10-Q Quarterly report
- 27 Aug 24 424B3 Prospectus supplement
- 27 Aug 24 8-K Endo Announces Ceo Transition
- 27 Aug 24 8-K Endo Reports Second-quarter 2024 Financial Results
- 1 Aug 24 EFFECT Notice of effectiveness
- 31 Jul 24 424B3 Prospectus supplement
- 26 Jul 24 S-1/A IPO registration (amended)
-
12 Jul 24 S-1 IPO registration
NDOI similar filings
Filing view
External links
Exhibit 21.1
List of Subsidiaries of Endo, Inc.
Subsidiary | Jurisdiction of Incorporation or Organization | Ownership by Endo, Inc. | ||
Endo Finance Holdings, Inc. | Delaware | Direct | ||
Endo Enterprise, Inc. | Delaware | Indirect | ||
Paladin Pharma Inc. | Canada | Indirect | ||
Endo USA, Inc. | Delaware | Indirect | ||
Endo US Holdings Luxembourg I S.a r.l. | Luxembourg | Indirect | ||
Operand Pharmaceuticals Holdco I Limited | Ireland | Indirect | ||
Endo Biologics Limited | Ireland | Indirect | ||
Endo Operations Limited | Ireland | Indirect | ||
Endo India Holdings, LLC | Delaware | Indirect | ||
Par Formulations Private Limited | India | Indirect | ||
Par Active Technologies Private Limited | India | Indirect | ||
Par Biosciences Private Limited | India | Indirect |